Stuart Mitchell Krassner is Director at SPECTRUM PHARMACEUTICALS INC (SPPI). They have made 5 open-market trades across 1 company since 2012, most recently 2019-05-28.
CIK 0001311636
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SPPI | 67,944 | $70K |
Shares reported on the most recent Form 4, priced at the 2019-05-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SPPI | SELL | 2019-05-24 | 2019-05-29 | $7.99 | $339K | +1.0% | +10.4% | -5.9% |
| SPPI | SELL | 2018-05-17 | 2018-05-18 | $18.94 | $800K | -5.2% | -2.2% | +12.3% |
| SPPI | SELL | 2018-03-21 | 2018-03-23 | $18.64 | $78K | -14.0% | +4.2% | +12.2% |
| SPPI | SELL | 2012-08-17 | 2012-08-20 | $12.58 | $72K | -18.2% | -2.4% | -2.4% |
| SPPI | SELL | 2012-07-13 | 2012-07-16 | $16.47 | $82K | -18.2% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.